Skip to content

The Application of High-Frequency Ultrasound in Assessing Nail Units in Patients with Inflammatory Nail Disorders and Healthy Volunteers

The Application of High-Frequency Ultrasound in Assessing Nail Units in Patients with Inflammatory Nail Disorders and Healthy Volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122205
Enrollment
Unknown
Registered
2026-04-10
Start date
2026-04-12
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory nail disease

Interventions

Gold Standard:Onychomycosis: Microscopic examination and culture of fungi/histopathological examination (PAS staining) Lichen planus: Clinical manifestations combined with a history of dermatology Na
Index test:High-frequency ultrasound imaging manifestations of different nail diseases

Sponsors

China-japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Psoriasis Group A (Group A): Patients aged 18 to 65 years (including the boundary value), with psoriasis nail changes on both hands, regardless of gender. Based on the clinical diagnosis by two associate senior dermatologists in the outpatient department or the histopathological criteria meeting the diagnostic criteria for psoriasis, the researchers determined that the condition had been stable for at least six months before screening. Understand the trial process and voluntarily sign the informed consent form. 2. Lichenus planus Group A (Group B): Patients aged 18 to 65 years (including the boundary value) with lichenus planus nail changes on both hands, regardless of gender. Based on the clinical diagnosis by two associate senior dermatologists in the outpatient department or the histopathological criteria meeting the diagnostic criteria for lichen planus, the researchers determined that the condition had been stable for at least six months before screening. Understand the trial process and voluntarily sign the informed consent form. 3. Eczema Group A (Group C): Patients aged 18 to 65 years (including the boundary value), with eczema changes in both fingernails, regardless of gender. Based on the clinical diagnosis by two associate senior dermatologists in the outpatient department or the histopathological criteria meeting the diagnostic criteria for eczema, the researchers determined that the condition had been stable for at least six months before screening. Understand the trial process and voluntarily sign the informed consent form. 4. Onychomycosis Group (Group D): Patients aged 18 to 65 years (including the boundary value) with onychomycosis changes on both fingernails, regardless of gender. The microscopic examination/culture of onychomycosis was positive, and the clinical diagnosis by two associate senior dermatologists in the outpatient department met the diagnostic criteria for onychomycosis. The researchers judged that the condition had been stable for at least 6 months before screening. Understand the trial process and voluntarily sign the informed consent form. 5. Healthy Volunteer Group (Group E): Healthy volunteers whose age, gender, occupation and BMI were matched with those of the psoriasis patient group; The clinical manifestations of healthy nails were diagnosed by two associate senior dermatologists in the outpatient department. Understand the trial process and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are other diseases in Unit A that may affect ultrasound evaluation, such as Unit A tumors; 2. People with nail trauma, nail grinding or nail art wear; 3. Situations where other researchers consider it inappropriate to be included in this study.

Design outcomes

Primary

MeasureTime frame
Deck thickness;Deck thickness;Accuracy;

Secondary

MeasureTime frame
Length of the nail root;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactYong Cui

China-japan Friendship Hospital

wuhucuiyong@vip.163.com+86 157 0162 5913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026